Diana I. Brixner, RPh, PhD, FAMCP, is currently Professor in the Department of Pharmacotherapy at the University of Utah College Of Pharmacy in Salt Lake City. She is also Executive Director of the Pharmacotherapy Outcomes Research Center, affiliated with the University of Utah Health Sciences Center, where she focuses on the design, conduct, training, and communication of pharmacoeconomic and outcomes research studies to demonstrate the value of pharmaceutical therapy. She is the Director of Outcomes for the Program in Personalized Health Care affiliated with the University of Utah Health Sciences Center, focusing on the tailoring of health care to the individual characteristics of the patient. These characteristics can include environment, social history, health history, family history, genetics, proteomics, along with the cost-effectiveness of these approaches vs. standard of care.

During her career, Dr. Brixner has published numerous articles in peer-reviewed journals, including the Journal of National Cancer Center Networks, Value in Health, Pharmacoepidemiology and Drug Safety, the American Journal of Managed Care and the Journal of Managed Care Pharmacy, authored three book chapters, has one issued patent, has been an invited speaker at a variety of national and international professional meetings. She is a founding member, served a two-year term on the Executive Board, currently serves as Co-Chair of the Real World Evidence Task Force and is a past president of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR). She is also a founding member of the Academy of Managed Care Pharmacy (AMCP), has served a three-year term on the Board of Directors, is currently on the AMCP Format Executive Committee, and is a Fellow of the Academy. In March of 2017 she was installed as President Elect of the Academy of Managed Care Pharmacy. 

Dr. Brixner is appointed as a Research Associate at the Institute of Public Health, Medical Decision Making and Health Technology Assessment in the Department of Public Health and Health Technology Assessment at UMIT - University for Health Sciences, Medical Informatics and Technology in Hall i.T., Austria. The appointment supports her international collaborations in oncology research, personalized medicine and value assessment.